MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jscai.2023.100970

Медицинская библиотека · Journal of the Society for Cardiovascular Angiography & Interventions · 2023

Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States.

Shavadia Jay S, Stanberry Larissa, Singh Jyotpal, Thao Kiahltone R, Ghasemzadeh Nima, Mercado Nestor, Nayak Keshav R, Alraies M Chadi, Bagur Rodrigo, Saw Jacqueline, Bagai Akshay, Bainey Kevin R, Madan Mina, Amlani Shy, Garberich Ross, Grines Cindy L, Garcia Santiago, Henry Timothy D, Dehghani Payam

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Important health care differences exist between the United States (US) and Canada, which may have been exacerbated during the pandemic. We compared clinical characteristics, treatment strategies, and clinical outcomes of patients with ST-segment elevation myocardial infarction (STEMI) and COVID-19 (STEMI-COVID) treated in the US and Canada.

METHODS

The North American COVID-19 Myocardial Infarction registry is a prospective, investigator-initiated study enrolling patients with STEMI with confirmed or suspected COVID-19 in the US and Canada. The primary end point was in-hospital mortality. Additionally, we explored associations between vaccination and clinical outcomes.

RESULTS

Of 853 patients with STEMI-COVID, 112 (13%) were enrolled in Canada, and compared with the US, patients in Canada were more likely to present with chest pain and less likely to have a history of heart failure, stroke/transient ischemic attack, pulmonary infiltrates or renal failure. In both countries, the primary percutaneous coronary intervention was the dominant reperfusion strategy, with no difference in door-to-balloon times; fibrinolysis was used less frequently in the US than in Canada. The adjusted in-hospital mortality was not different between the 2 countries (relative risk [RR], 1.0; 95% CI, 0.46-2.72; P = 1.0). However, the risk of in-hospital mortality was significantly higher in unvaccinated compared with vaccinated patients with STEMI-COVID (RR, 4.7; 95% CI, 1.7-11.53; P = .015).

CONCLUSIONS

Notable differences in morbidities and reperfusion strategies were evident between patients with STEMI-COVID in the US compared with Canada. No differences were noted for in-hospital mortality. Vaccination, regardless of region, appeared to associate with a lower risk of in-hospital mortality strongly.

Для цитирования: Shavadia Jay S, Stanberry Larissa, Singh Jyotpal, Thao Kiahltone R, Ghasemzadeh Nima, Mercado Nestor, Nayak Keshav R, Alraies M Chadi, Bagur Rodrigo, Saw Jacqueline, Bagai Akshay, Bainey Kevin R, Madan Mina, Amlani Shy, Garberich Ross, Grines Cindy L, Garcia Santiago, Henry Timothy D, Dehghani Payam. Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States.. Journal of the Society for Cardiovascular Angiography & Interventions. 2023. DOI: 10.1016/j.jscai.2023.100970.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.